HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators
Authors
Keywords
PU-H71, Radiosensitivity, HSP90 inhibitor, Breast cancer, Metastasis
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-14
DOI
10.1007/s00210-019-01725-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma
- (2017) Lisa Giulino-Roth et al. MOLECULAR CANCER THERAPEUTICS
- HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment
- (2017) A Guo et al. ONCOGENE
- STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway
- (2017) Yang Liu et al. Oncotarget
- Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells
- (2016) Colin Rae et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy
- (2016) Huizi Keiko Li et al. JOURNAL OF RADIATION RESEARCH
- The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining
- (2016) Younghyun Lee et al. RADIOTHERAPY AND ONCOLOGY
- Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists
- (2015) Nuray Erin et al. BREAST CANCER RESEARCH AND TREATMENT
- Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer
- (2015) Jalaj Gupta et al. FEBS Journal
- MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells
- (2015) Yoojung Kwon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma
- (2015) Rebecca L. Goldstein et al. JOURNAL OF CLINICAL INVESTIGATION
- Maximizing the Therapeutic Potential of HSP90 Inhibitors
- (2015) L. M. Butler et al. MOLECULAR CANCER RESEARCH
- Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors
- (2015) SHINSUKE HASHIDA et al. ONCOLOGY REPORTS
- Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model
- (2015) Xing Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Application of chemokine receptor antagonist with stents reduces local inflammation and suppresses cancer growth
- (2015) Ai-Wu Mao et al. TUMOR BIOLOGY
- CXCR4 in breast cancer: oncogenic role and therapeutic targeting
- (2015) Qinghua Yao et al. Drug Design Development and Therapy
- Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner
- (2015) Surajit Pathak et al. Oncotarget
- A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species
- (2015) Hongliang Zong et al. Cell Reports
- Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms
- (2014) Neha Bhagwat et al. BLOOD
- Dissection of the Hormetic Curve: Analysis of Components and Mechanisms
- (2014) Volodymyr I. Lushchak Dose-Response
- Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer
- (2014) Anton G.T. Terwisscha van Scheltinga et al. EUROPEAN JOURNAL OF CANCER
- Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response
- (2014) N Erin et al. ONCOGENE
- Erratum to: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
- (2013) Ganji Purnachandra Nagaraju et al. ANGIOGENESIS
- Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma
- (2013) Nuray Erin et al. BREAST CANCER RESEARCH AND TREATMENT
- Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
- (2013) Nishant Gandhi et al. CANCER BIOLOGY & THERAPY
- Radiosensitization of human lung cancer cells by the novel purine-scaffold Hsp90 inhibitor, PU-H71
- (2013) TATSUYA SEGAWA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer
- (2013) Lisha Xiang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- PU-H71 effectively induces degradation of IκB kinase β in the presence of TNF-α
- (2013) Zhuling Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cytokines driving breast cancer stemness
- (2013) Andrew R. Chin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma
- (2013) Srikanth R. Ambati et al. Molecular Oncology
- The role of IL-6 in the radiation response of prostate cancer
- (2013) Chun-Te Wu et al. Radiation Oncology
- Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation
- (2013) Chongyu Zhang et al. TUMOR BIOLOGY
- Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis
- (2012) Marek Wagner et al. ANGIOGENESIS
- Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy
- (2012) Soichiro Yoshida et al. CELL CYCLE
- Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
- (2011) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Hsp90 Inhibitor-Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
- (2011) K. Ha et al. MOLECULAR CANCER THERAPEUTICS
- Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
- (2011) Kamalika Moulick et al. Nature Chemical Biology
- Hsp90 and co-chaperones twist the functions of diverse client proteins
- (2009) Abbey Zuehlke et al. BIOPOLYMERS
- Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
- (2009) A Seaton et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
- (2009) E. Caldas-Lopes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered gene expression in breast cancer liver metastases
- (2008) Nuray Erin et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started